|
1
|
Réus GZ, Vieira FG, Abelaira HM, Michels
M, Tomaz DB, dos Santos MA, Carlessi AS, Neotti MV, Matias BI, Luz
JR, et al: MAPK signaling correlates with the antidepressant
effects of ketamine. J Psychiatr Res. 55:15–21. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Kessler RC and Wang PS: The descriptive
epidemiology of commonly occurring mental disorders in the United
States. Ann Rev Public Health. 29:115–129. 2008. View Article : Google Scholar
|
|
3
|
Manji HK, Drevets WC and Charney DS: The
cellular neurobiology of depression. Nat Med. 7:541–547. 2001.
View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Steru L, Chermat R, Thierry B and Simon P:
The tail suspension test: A new method for screening
antidepressants in mice. Psychopharmacology (Berl). 85:367–370.
1985. View Article : Google Scholar
|
|
5
|
Komiya M, Takeuchi T and Harada E: Lemon
oil vapor causes an anti-stress effect via modulating the 5-HT and
DA activities in mice. Behav Brain Res. 172:240–249. 2006.
View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Ma Z, Ji W, Qu R, Wang M, Yang W, Zhan Z,
Fu Q and Ma S: Metabonomic study on the antidepressant-like effects
of banxia houpu decoction and its action mechanism. Evid Based
Complement Alternat Med. 2013:2137392013. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Kang A, Hao H, Zheng X, Liang Y, Xie Y,
Xie T, Dai C, Zhao Q, Wu X, Xie L and Wang G: Peripheral
anti-inflammatory effects explain the ginsenosides paradox between
poor brain distribution and anti-depression efficacy. J
Neuroinflammation. 8:1002011. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Kennedy SH: A review of antidepressant
treatments today. Eur Neuropsychopharm. 16(Suppl): S619–S623. 2006.
View Article : Google Scholar
|
|
9
|
Novak M and Vetvicka V: Beta-glucans,
history and the present: Immunomodulatory aspects and mechanisms of
action. J Immunotoxicol. 5:47–57. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Jin L, Wu F, Li X, Li H, Du C, Jiang Q,
You J, Li S and Xu Y: Anti-depressant effects of aqueous extract
from Acanthopanax senticosus in mice. Phytother Res. 27:1829–1833.
2013. View
Article : Google Scholar : PubMed/NCBI
|
|
11
|
Dar A, Khatoon S, Rahman G and
Atta-Ur-Rahman: Anti-depressant activities of areca catechu fruit
extract. Phytomedicine. 4:41–45. 1997. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Peng L, Zhang X, Kang DY, Liu XT and Hong
Q: Effectiveness and safety of wuling capsule for post stroke
depression: A systematic review. Complement Ther Med. 22:549–566.
2014. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Wang XJ, Li J, Zou QD and Jin L: Wuling
capsule for climacteric patients with depression and anxiety state:
A randomized, positive parallel controlled trial. Zhong Xi Yi Jie
He Xue Bao. 7:1042–1046. 2009.In Chinese. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Wang X, Liang QM, Li TT, Zhi R, Zhang N
and Lu J: Study on extraction and anti-oxidation of Marasmius
androsaceus mycelium polysaccharides. Food Sci Technol. 12:80–83.
2006.
|
|
15
|
Ye WF, Yang XT, Chen Y and Li QL:
Long-time analgesic effect of Marasmius androsaceus in rats. Zhong
yao yao li yu lin chuang. 18:19–21. 2002.In Chinese.
|
|
16
|
Gao Yang YX-l and Xu Duo-Duo: Glycopeptide
physicochemical properties and analgesic effect of Marasmius
androsaceus. Changchun Zhong yi xue yuan xue bao. 777–778. 2013.In
Chinese.
|
|
17
|
Kim SW, Hwang HJ, Xu CP, Sung JM, Choi JW
and Yun JW: Optimization of submerged culture process for the
production of mycelial biomass and exo-polysaccharides by Cordyceps
militaris C738. J Appl Microbiol. 94:120–126. 2003. View Article : Google Scholar
|
|
18
|
Chen H, Yan M, Zhu J and Xu X: Enhancement
of exo-polysaccharide production and antioxidant activity in
submerged cultures of Inonotus obliquus by lignocellulose
decomposition. J Ind Microbiol Biotechnol. 38:291–298. 2011.
View Article : Google Scholar
|
|
19
|
Shih IL: Microbial exo-polysaccharides for
biomedical applications. Mini Rev Med Chem. 10:1345–1355. 2010.
View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Sun Na-Xin YG-W and An Li-Guo:
Anti-hyperglycemic activities of exopolysaccharides from Cordyceps
militaris in diabetic mice induced by multiple low-dose
streptozotocoin. Shipin Kexue (Beijing). 288–295. 2013.In
Chinese.
|
|
21
|
Lan Ying PZ-F, Zhang Song and Yang
Xiao-Bing: The Influence of exopolysaccharide extract of Morchella
conica on fruit Fly's life-span. Zhong guo shi yong jun bian ji bu.
43–45. 2010.In Chinese.
|
|
22
|
Yan H, Zhu D, Xu D, Wu J and Bian X: A
study on Cordyceps militaris polysaccharide purification,
composition and activity analysis. Afr J Biotechnol. 7:4004–4009.
2008.
|
|
23
|
Porsolt RD, Bertin A and Jalfre M:
Behavioral despair in mice: A primary screening test for
antidepressants. Arch Int Pharmacodyn Ther. 229:327–336.
1977.PubMed/NCBI
|
|
24
|
Pesarico AP, Sampaio TB, Stangherlin EC,
Mantovani AC, Zeni G and Nogueira CW: The antidepressant-like
effect of 7-fluoro-1,3-diphenylisoquinoline-1-amine in the mouse
forced swimming test is mediated by serotonergic and dopaminergic
systems. Prog Neuropsychopharmacol Biol Psychiatry. 54:179–186.
2014. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Xiang H, Liu Y, Zhang B, Huang J, Li Y,
Yang B, Huang Z, Xiang F and Zhang H: The antidepressant effects
and mechanism of action of total saponins from the caudexes and
leaves of Panax notoginseng in animal models of depression.
Phytomedicine. 18:731–738. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Yang CL, Chik SC, Li JC, Cheung BK and Lau
AS: Identification of the bioactive constituent and its mechanisms
of action in mediating the anti-inflammatory effects of black
cohosh and related Cimicifuga species on human primary blood
macrophages. J Med Chem. 52:6707–6715. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Noble JE and Bailey MJ: Quantitation of
protein. Methods Enzymol. 463:73–95. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Gao L, Liu G, Kang J, Niu M, Wang Z, Wang
H, Ma J and Wang X: Paclitaxel nanosuspensions coated with P-gp
inhibitory surfactants: I. Acute toxicity and pharmacokinetics
studies. Colloids Surf B Biointerfaces. 111:277–281. 2013.
View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Willner P: The validity of animal models
of depression. Psychopharmacology (Berl). 83:1–16. 1984. View Article : Google Scholar
|
|
30
|
Gao S, Cui YL, Yu CQ, Wang QS and Zhang Y:
Tetrandrine exerts antidepressant-like effects in animal models:
Role of brain-derived neurotrophic factor. Behav Brain Res.
238:79–85. 2013. View Article : Google Scholar
|
|
31
|
Cryan JF and Lucki I: Antidepressant-like
behavioral effects mediated by 5-Hydroxytryptamine (2C) receptors.
J Pharmacol Exp Ther. 295:1120–1126. 2000.PubMed/NCBI
|
|
32
|
Page ME, Detke MJ, Dalvi A, Kirby LG and
Lucki I: Serotonergic mediation of the effects of fluoxetine, but
not desipramine, in the rat forced swimming test.
Psychopharmacology (Berl). 147:162–167. 1999. View Article : Google Scholar
|
|
33
|
Handley SL and Singh L: Modulation of
5-hydroxytryptamine-induced head-twitch response by drugs acting at
GABA and related receptors. Br J Pharmacol. 86:297–303. 1985.
View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Peroutka SJ, Lebovitz RM and Snyder SH:
Two distinct central serotonin receptors with different
physiological functions. Science. 212:827–829. 1981. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Fukuda K: 5-HTP hypothesis of
schizophrenia. Med Hypotheses. 82:20–23. 2014. View Article : Google Scholar
|
|
36
|
Zhang ZJ, Wang D, Man SC, Ng R, McAlonan
GM, Wong HK, Wong W, Lee J and Tan QR: Platelet 5-HT (1A) receptor
correlates with major depressive disorder in drug-free patients.
Prog Neuropsychopharmacol Biol Psychiatry. 53:74–79. 2014.
View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Gardier AM, Malagié I, Trillat AC, Jacquot
C and Artigas F: Role of 5-HT1A autoreceptors in the mechanism of
action of serotoninergic antidepressant drugs: Recent findings from
in vivo microdialysis studies. Fundam Clin Pharmacol. 10:16–27.
1996. View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Rainer Q, Nguyen HT, Quesseveur G, Gardier
AM, David DJ and Guiard BP: Functional status of somatodendritic
serotonin 1A autoreceptor after long-term treatment with fluoxetine
in a mouse model of anxiety/depression based on repeated
corticosterone administration. Mol Pharmacol. 81:106–112. 2012.
View Article : Google Scholar
|
|
39
|
Haenisch B and Bönisch H: Depression and
antidepressants: Insights from knockout of dopamine, serotonin or
noradrenaline re-uptake transporters. Pharmacol Ther. 129:352–368.
2011. View Article : Google Scholar
|
|
40
|
Tashkin DP, Rabinoff M, Noble EP, Ritchie
TL, Simmons MS and Connett J: Association of dopamine-related gene
alleles, smoking behavior and decline in FEV1 in subjects with
COPD: findings from the lung health study. COPD. 9:620–628. 2012.
View Article : Google Scholar : PubMed/NCBI
|
|
41
|
Madras BK, Fahey MA, Miller GM, De La
Garza R, Goulet M, Spealman RD, Meltzer PC, George SR, O'Dowd BF,
Bonab AA, et al: Non-amine-based dopamine transporter (reuptake)
inhibitors retain properties of amine-based progenitors. Eur J
Pharmacol. 479:41–51. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
42
|
Cunha MP, Pazini FL, Oliveira Á, Bettio
LE, Rosa JM, Machado DG and Rodrigues AL: The activation of
α1-adrenoceptors is implicated in the antidepressant-like effect of
creatine in the tail suspension test. Prog Neuropsychopharmacology
Biol Psychiatry. 44:39–50. 2013. View Article : Google Scholar
|
|
43
|
Rovin ML, Boss-Williams KA, Alisch RS,
Ritchie JC, Weinshenker D, West CH and Weiss JM: Influence of
chronic administration of antidepressant drugs on mRNA for galanin,
galanin receptors and tyrosine hydroxylase in catecholaminergic and
serotonergic cell-body regions in rat brain. Neuropeptides.
46:81–91. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
44
|
Nagatsu T, Levitt M and Udenfriend S:
Tyrosine Hydroxylase. The initial step in norepinephrine
biosynthesis. J Biol Chem. 239:2910–2917. 1964.PubMed/NCBI
|
|
45
|
Lambert G, Johansson M, Agren H and
Friberg P: Reduced brain norepinephrine and dopamine release in
treatment-refractory depressive illness: Evidence in support of the
catecholamine hypothesis of mood disorders. Arch Gen Psychiatry.
57:787–793. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
46
|
Ainsworth K, Smith SE, Zetterstrom TS, Pei
Q, Franklin M and Sharp T: Effect of antidepressant drugs on
dopamine D1 and D2 receptor expression and dopamine release in the
nucleus accumbens of the rat. Psychopharmacology (Berl).
140:470–477. 1998. View Article : Google Scholar
|
